ETOPOSIDE (VP-16-213) IN MALIGNANT BRAIN-TUMORS - A PHASE-II STUDY

被引：89
作者：
TIRELLI, U
DINCALCI, M
CANETTA, R
TUMOLO, S
FRANCHIN, G
VERONESI, A
GALLIGIONI, E
TROVO, MG
ROSSI, C
GRIGOLETTO, E
机构：
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] BRISTOL MYERS CO,DIV PHARMACEUT RES & DEV,NEW YORK,NY
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 05期
关键词：
D O I：
10.1200/JCO.1984.2.5.432
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：432 / 437
页数：6
相关论文
共 29 条
  • [21] MAROUN JA, 1982, P AM SOC CLIN ONCOL, V1, P140
  • [22] RADICE PA, 1979, CANCER TREAT REP, V63, P1231
  • [23] SKLANSKY BD, 1974, CANCER-AM CANCER SOC, V33, P460, DOI 10.1002/1097-0142(197402)33:2<460::AID-CNCR2820330222>3.0.CO
  • [24] 2-5
  • [25] SPREMULLI E, 1980, CANCER TREAT REP, V64, P147
  • [26] ACTIVITY OF A NEW GLYCOSIDIC LIGNAN DERIVATIVE (VP 16-213) RELATED TO PODOPHYLLOTOXIN IN EXPERIMENTAL TUMORS
    STAHELIN, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1973, 9 (03) : 215 - 221
  • [27] STEWART DJ, 1983, P AM ASSOC CANC RES, V24, P133
  • [28] SWEET DL, 1979, CANCER TREAT REP, V63, P1707
  • [29] Yamamoto H, 1979, Acta Neurochir Suppl (Wien), V28, P616
123